American Journal of Kidney Diseases

Risk Implications of the New CKD Epidemiology Collaboration (CKD-EPI) Equation Compared With the MDRD Study Equation for Estimated GFR: The Atherosclerosis Risk in Communities (ARIC) Study

Published:March 02, 2010DOI:


      The Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) recently published an equation for estimated glomerular filtration rate (eGFR) using the same variables (serum creatinine level, age, sex, and race) as the Modification of Diet in Renal Disease (MDRD) Study equation. Although the CKD-EPI equation estimates GFR more precisely compared with the MDRD Study equation, whether this equation improves risk prediction is unknown.

      Study Design

      Prospective cohort study, the Atherosclerosis Risk in Communities (ARIC) Study.

      Setting & Participants

      13,905 middle-aged participants without a history of cardiovascular disease with median follow-up of 16.9 years.



      Outcomes & Measurements

      We compared the association of eGFR in categories (≥120, 90-119, 60-89, 30-59, and <30 mL/min/1.73 m2) using the CKD-EPI and MDRD Study equations with risk of incident end-stage renal disease, all-cause mortality, coronary heart disease, and stroke.


      The median value for eGFRCKD-EPI was higher than that for eGFRMDRD (97.6 vs 88.8 mL/min/1.73 m2; P < 0.001). The CKD-EPI equation reclassified 44.9% (n = 3,079) and 43.5% (n = 151) of participants with eGFRMDRD of 60-89 and 30-59 mL/min/1.73 m2, respectively, upward to a higher eGFR category, but reclassified no one with eGFRMDRD of 90-119 or <30 mL/min/1.73 m2, decreasing the prevalence of CKD stages 3-5 from 2.7% to 1.6%. Participants with eGFRMDRD of 30-59 mL/min/1.73 m2 who were reclassified upward had lower risk compared with those who were not reclassified (end-stage renal disease incidence rate ratio, 0.10 [95% CI, 0.03-0.33]; all-cause mortality, 0.30 [95% CI, 0.19-0.48]; coronary heart disease, 0.36 [95% CI, 0.21-0.61]; and stroke, 0.50 [95% CI, 0.24-1.02]). Similar results were observed for participants with eGFRMDRD of 60-89 mL/min/1.73 m2. More frequent reclassification of younger, female, and white participants explained some of these trends. Net reclassification improvement in participants with eGFR < 120 mL/min/1.73 m2 was positive for all outcomes (P < 0.001).


      Limited number of cases with eGFR < 60 mL/min/1.73 m2 and no measurement of albuminuria.


      The CKD-EPI equation more appropriately categorized individuals with respect to long-term clinical risk compared with the MDRD Study equation, suggesting improved clinical usefulness in this middle-aged population.

      Index Words

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to American Journal of Kidney Diseases
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Vassalotti J.A.
        • Stevens L.A.
        • Levey A.S.
        Testing for chronic kidney disease: a position statement from the National Kidney Foundation.
        Am J Kidney Dis. 2007; 50: 169-180
        • Stevens L.A.
        • Coresh J.
        • Schmid C.H.
        • et al.
        Estimating GFR using serum cystatin C alone and in combination with serum creatinine: a pooled analysis of 3,418 individuals with CKD.
        Am J Kidney Dis. 2008; 51: 395-406
        • National Kidney Foundation
        K/DOQI Clinical Practice Guidelines for Chronic Kidney Disease: evaluation, classification, and stratification.
        Am J Kidney Dis. 2002; 39: S1-S266
        • The National Institute for Health and Clinical Excellence
        Chronic kidney disease: early identification and management of chronic kidney disease in adults in primary and secondary care.
        (Accessed July 27, 2009)
        • Sarnak M.J.
        • Levey A.S.
        • Schoolwerth A.C.
        • et al.
        Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention.
        Circulation. 2003; 108: 2154-2169
        • Miller W.G.
        Reporting estimated GFR: a laboratory perspective.
        Am J Kidney Dis. 2008; 52: 645-648
        • Levey A.S.
        • Bosch J.P.
        • Lewis J.B.
        • Greene T.
        • Rogers N.
        • Roth D.
        A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation.
        Ann Intern Med. 1999; 130: 461-470
        • Rule A.D.
        • Larson T.S.
        • Bergstralh E.J.
        • Slezak J.M.
        • Jacobsen S.J.
        • Cosio F.G.
        Using serum creatinine to estimate glomerular filtration rate: accuracy in good health and in chronic kidney disease.
        Ann Intern Med. 2004; 141: 929-937
        • Rule A.D.
        • Gussak H.M.
        • Pond G.R.
        • et al.
        Measured and estimated GFR in healthy potential kidney donors.
        Am J Kidney Dis. 2004; 43: 112-119
        • Stevens L.A.
        • Coresh J.
        • Greene T.
        • Levey A.S.
        Assessing kidney function—measured and estimated glomerular filtration rate.
        N Engl J Med. 2006; 354: 2473-2483
        • Stevens L.A.
        • Coresh J.
        • Feldman H.I.
        • et al.
        Evaluation of the Modification of Diet in Renal Disease Study equation in a large diverse population.
        J Am Soc Nephrol. 2007; 18: 2749-2757
        • Levey A.S.
        • Stevens L.A.
        • Schmid C.H.
        • et al.
        A new equation to estimate glomerular filtration rate.
        Ann Intern Med. 2009; 150: 604-612
        • The ARIC Investigators
        The Atherosclerosis Risk in Communities (ARIC) Study: design and objectives.
        Am J Epidemiol. 1989; 129: 687-702
        • The ARIC Investigators
        Operations Manual 7: Blood Collection and Processing.
        National Heart, Lung and Blood Institute, Bethesda, MD1987
        • Casale P.N.
        • Devereux R.B.
        • Alonso D.R.
        • Campo E.
        • Kligfield P.
        Improved sex-specific criteria of left ventricular hypertrophy for clinical and computer interpretation of electrocardiograms: validation with autopsy findings.
        Circulation. 1987; 75: 565-572
        • Kottgen A.
        • Russell S.D.
        • Loehr L.R.
        • et al.
        Reduced kidney function as a risk factor for incident heart failure: the Atherosclerosis Risk in Communities (ARIC) Study.
        J Am Soc Nephrol. 2007; 18: 1307-1315
        • Eckfeldt J.H.
        • Chambless L.E.
        • Shen Y.L.
        Short-term, within-person variability in clinical chemistry test results.
        Arch Pathol Lab Med. 1994; 118: 496-500
        • Coresh J.
        • Astor B.C.
        • McQuillan G.
        • et al.
        Calibration and random variation of the serum creatinine assay as critical elements of using equations to estimate glomerular filtration rate.
        Am J Kidney Dis. 2002; 39: 920-929
        • Selvin E.
        • Manzi J.
        • Stevens L.A.
        • et al.
        Calibration of serum creatinine in the National Health and Nutrition Examination Surveys (NHANES) 1988-1994, 1999-2004.
        Am J Kidney Dis. 2007; 50: 918-926
        • Levey A.S.
        • Coresh J.
        • Greene T.
        • et al.
        Using standardized serum creatinine values in the Modification of Diet in Renal Disease Study equation for estimating glomerular filtration rate.
        Ann Intern Med. 2006; 145: 247-254
        • White A.D.
        • Folsom A.R.
        • Chambless L.E.
        • et al.
        Community surveillance of coronary heart disease in the Atherosclerosis Risk in Communities (ARIC) Study: methods and initial two years' experience.
        J Clin Epidemiol. 1996; 49: 223-233
        • Rathore S.S.
        • Hinn A.R.
        • Cooper L.S.
        • Tyroler H.A.
        • Rosamond W.D.
        Characterization of incident stroke signs and symptoms: findings from the Atherosclerosis Risk in Communities Study.
        Stroke. 2002; 33: 2718-2721
        • Rosamond W.D.
        • Folsom A.R.
        • Chambless L.E.
        • et al.
        Stroke incidence and survival among middle-aged adults: 9-year follow-up of the Atherosclerosis Risk in Communities (ARIC) cohort.
        Stroke. 1999; 30: 736-743
        • Wattanakit K.
        • Folsom A.R.
        • Selvin E.
        • Coresh J.
        • Hirsch A.T.
        • Weatherley B.D.
        Kidney function and risk of peripheral arterial disease: results from the Atherosclerosis Risk in Communities (ARIC) Study.
        J Am Soc Nephrol. 2007; 18: 629-636
        • Harrell Jr, F.E.
        • Lee K.L.
        • Mark D.B.
        Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors.
        Stat Med. 1996; 15: 361-387
        • Pencina M.J.
        • D'Agostino Sr, R.B.
        • D'Agostino Jr, R.B.
        • Vasan R.S.
        Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond.
        Stat Med. 2008; 27 (discussion 207-112): 157-172
        • Wilson P.W.
        • D'Agostino R.B.
        • Levy D.
        • Belanger A.M.
        • Silbershatz H.
        • Kannel W.B.
        Prediction of coronary heart disease using risk factor categories.
        Circulation. 1998; 97: 1837-1847
        • Chambless L.E.
        • Folsom A.R.
        • Sharrett A.R.
        • et al.
        Coronary heart disease risk prediction in the Atherosclerosis Risk in Communities (ARIC) Study.
        J Clin Epidemiol. 2003; 56: 880-890
        • Shlipak M.G.A.B.
        • Praught M.L.B.
        • Sarnak M.J.C.
        Update on cystatin C: new insights into the importance of mild kidney dysfunction.
        Curr Opin Nephrol Hypertens. 2006; 15: 270-275
        • Rainey P.M.
        Automatic reporting of estimated glomerular filtration rate—jumping the gun?.
        Clin Chem. 2006; 52: 2184-2187
        • Hsu C.Y.
        • Lin F.
        • Vittinghoff E.
        • Shlipak M.G.
        Racial differences in the progression from chronic renal insufficiency to end-stage renal disease in the United States.
        J Am Soc Nephrol. 2003; 14: 2902-2907

      Linked Article